$CTM Cashflow Statement | Understand Stock

$CTM

$0.51 +$0.01 (2.53%) Close

$CTM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided (used in) by operating activities:
Depreciation and amortization
Amortization of discounts, premiums and deferred cost
Share-based compensation
Deferred tax provision
Financing fees and bank charges
Gain on lease termination
Gain on sale of reporting unit
Gain on sale of fixed assets
Financing fee and bank charges for note payable and advances on revolving credit line
Realized gain on investment
Goodwill impairment loss
Legal fees paid out of proceeds from note payable
Lease cost
Change in fair value of contingent earnout
Change in fair value of derivative liabilities
Gain from timing difference on issuance of shares

Changes in assets and liabilities
Accounts receivable
Proceeds From Factoring Accounts Receivable
Prepaid expenses and other current assets
Contract asset and liabilities
Payment of transaction costs in acquisition of business
Lease liabilities
Accounts payable and accrued expenses
Net cash (used in) provided by operating activities
Cash flows from investing activities:
Cash paid in acquisition of LSG
Acquisition of business, cash paid to seller
Sale of subsidiary, cash received from buyer
Cash from factoring
Investment in Joint Ventures
Acquisition of business, cash received from seller
MFSI
Merrison
SSI
Total acquisition of business, cash received from seller

Sale of investment
Purchases of intangible assets
Investment in captive insurance entity
Purchases of fixed assets
Net cash (used in) provided by investing activities

Cash flows from financing activities:
Proceeds from revolving credit line
Proceeds from issuance of common stock
Repayment of line of credit, net
Settlement of stock compensation in cash
Payment of debt issuance costs
Proceeds from issuance of preferred and common stock, and regular warrants, net of issuance costs
Proceeds from note payable
Proceeds from exercise of stock options
Proceeds from stock offering related to uplisting
Preferred stock dividend
Loss on induced conversion
Repayment of convertible note payable – related party
Repayment of notes payable
Net cash (used in) provided by financing activities

Net increase (decrease) in cash
Cash and restricted cash - beginning of period
Cash and restricted cash - end of period
Supplemental disclosures:
Cash paid for interest
Cash paid for income taxes
Summary of noncash activities:
Extinguishment of debt discount - derivative liabilities
Extinguishment of debt discount related to debt issuance
Debt discount on note payable
Partial conversion of note payable
Partial Conversion Of Notes Payable
Conversion Of Purchase Consideration Payable

Beneficial Conversion Feature ("BCF") discount on convertible note, net of tax
Conversion of convertible notes – related parties and accrued interest to common stock
Common shares issued for obligation to issue shares
Derivative liabilities incurred for note payable
Extinguishment of derivative liability
Acquisition of business, common stock issued to seller
Gain on extinguishment of convertible note payable - related party
Adjustment to contingent consideration and customer relationships
Fair value adjustment recognized on issuance of common stock in Securities Purchase Agreement
Deferred issuance costs
Conversion of Series B preferred shares to common stock
Cancellation of shares offsetting acquisition of business
Derecognition of lease liability
Derecognition of ROU asset

Comments